Position · Core / Quality Compounders
Intel Corporation (INTC)
Compare vs. competitors: AMD vs. Intel vs. NVIDIA →
Read the full Q1 2026 earnings report →
Subscribe to INTC updates (RSS) →
Download full 3-statement model (.xlsx) →
Thesis StatementIntel's foundry turnaround is a real bet on U.S. domestic chip manufacturing, now validated by actual external customer deals rather than political rhetoric alone.
Core Thesis
Intel remains the CPU share leader in both PC and server markets and pioneered the x86 architecture, but the real thesis is a turnaround bet: whether Intel Foundry can land real external customers and catch process-node execution up to leading-edge...
Financial Metrics
- Market Cap$638B
- P/E (TTM)N/A — unprofitable on a trailing basis
- EPS (TTM)−$0.60
- Div. Yield0.00%
- Price$120.35
Bear Case
Foundry execution keeps disappointing, competitors extend their process-node lead, and Intel stays unprofitable for longer than the market currently expects — at a $638B market cap with negative trailing earnings, the stock is pricing in a turnaround that...
Investment Thesis
- The Thesis
- Intel remains the CPU share leader in both PC and server markets and pioneered the x86 architecture, but the real thesis is a turnaround bet: whether Intel Foundry can land real external customers and catch process-node execution up to leading-edge competitors, restoring the manufacturing edge the company used to have.
- The Catalyst
- Foundry landing a marquee external customer or hitting a real process-node milestone would be the concrete proof point that the turnaround is working, rather than another quarter of promises — I've sized this small on purpose as a turnaround bet, not a quality-compounder position.
- The Risk
- Intel is currently unprofitable on a trailing basis, and at a $638B market cap with negative EPS, the stock is already pricing in a turnaround that hasn't shown up yet — foundry execution could keep disappointing for longer than the market expects.
- The Connection
- Part of my semiconductor theme alongside SNDK, AMD, and MU, though the thesis here is different — a manufacturing turnaround bet rather than a direct AI-demand play.
Pre-Mortem Thesis Invalidation Parameters
Codified in advance, before any of these have happened, so a future decision to hold or exit isn't rationalized in the moment. If a condition below is met, the thesis as written is invalidated and the position gets re-underwritten from scratch — not automatically sold, but automatically questioned.
| Metric / Event | Automatic Review Trigger |
|---|---|
| Foundry Operating Margin | Stays negative beyond the company's own guided breakeven timeline. |
| 18A / 14A Process Milestones | Yields or timeline slip versus the most recently guided targets. |
| Market cap | $638B |
|---|---|
| P/E ratio (TTM) | N/A — unprofitable on a trailing basis |
| EPS (TTM) | −$0.60 |
| Dividend yield | 0.00% |
| Shares outstanding | 5.03B |
| Sector | Semiconductors & related devices |
| EBITDAEarnings Before Interest, Taxes, Depreciation, and Amortization — a measure of operating profitability before financing and accounting decisions. EV/EBITDA compares a company's full value (including debt) to this figure, often used to compare companies with different capital structures. | EV/EBITDA 23.73x (5yr EBITDA growth −36.8%) |
| PEG ratioPrice/Earnings-to-Growth: the P/E ratio divided by expected earnings growth. Below 1.0 is often read as cheap relative to growth; above suggests the market is pricing in a lot of future growth already. Different providers use different growth-rate assumptions, so figures vary by source. | N/A (negative EBITDA growth) |
| Capex | −$13.10B (TTM) |
Valuation Logic
With trailing EPS still negative, there is no P/E to anchor the valuation; the entire case rests on external foundry revenue actually showing up in future quarters' financial statements, not on deal-announcement sentiment.
About the business
Intel designs and manufactures microprocessors for PCs and data centers, pioneered the x86 architecture, and remains the CPU share leader in both PC and server markets. It's trying to rebuild its chip manufacturing business, Intel Foundry, while developing competitive products in its core business.
Why I own it, sized small
This is a turnaround bet, not a quality-compounder bet in the usual sense — I've sized it small on purpose. Intel is currently unprofitable on a trailing basis (negative EPS), which is exactly why it's 4.91% of the book instead of a larger position: I want exposure to the foundry turnaround thesis without betting heavily on execution I can't verify yet.
Risk/Reward Profile
| Bull Case | Bear Case |
|---|---|
| Intel Foundry lands real external customers, process-node execution catches up to leading-edge competitors, and the company returns to sustained GAAP profitability as both products and foundry scale. | Foundry execution keeps disappointing, competitors extend their process-node lead, and Intel stays unprofitable for longer than the market currently expects — at a $638B market cap with negative trailing earnings, the stock is pricing in a turnaround that hasn't shown up yet. |
Download this position's data
Fundamentals, scenario matrix, and risk/reward table — exported exactly as published on this page, no reformatting.